期刊
DRUG AND ALCOHOL DEPENDENCE
卷 188, 期 -, 页码 232-238出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.drugalcdep.2018.04.010
关键词
Buprenorphine treatment; Prisoners; Opioid use disorder; Official arrest records; Criminal activity
资金
- National Institute on Drug Abuse (NIDA) [R01DA021579]
- NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021579] Funding Source: NIH RePORTER
Background: This secondary analysis of a randomized trial examines the association between initiation of buprenorphine treatment prior to, versus post-release, and rearrests during the 12-months following release. Methods: Official rearrest data (N = 199) for the 12-months post-release were examined. Four outcomes were measured: (1) rearrested (yes/no), (2) time to rearrest, (3) number of rearrests, and (4) severity of charges (less severe vs. severe). Results: A minority (43.1%) of the sample were rearrested (N = 91). There were no significant differences between study conditions in the proportion of rearrested participants [P = 0.28] nor in the mean number of arrests [P = 0.15]. Likewise, the condition was not a significant predictor of the hazard of rearrest [p = 0.10]. The mean number of days until rearrest for the in prison vs. post-release buprenorphine conditions were not significantly different (205.8 days (SD = 104.6) vs. 170.8 days (SD = 113.1), respectively; P = 0.13]. Treatment condition was not a significant predictor of the likelihood of rearrest for a severe crime compared to a less severe crime [P = 0.09]. Conclusion: Despite the parent study finding of higher rates of post-release drug treatment entry in the group assigned to start buprenorphine treatment prior to, compared to post-release, there were no significant differences in the proportion of individuals arrested, the mean number of arrests, the time to first arrest, or the severity of their charges.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据